Pinnacle Foods Inc. PF
Set alert
At close · Jun 28
52-week range unavailable
- YTD
- -100.00%
- 1 year
- -100.00%
- Open
- 67.15
- Prev close
- 66.66
- Mkt cap
- 0
- Vol
- 13.94M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 66.63
- High
- 67.19
- Earnings
- Oct 25, 2018
News
2 weeks ago accessnewswire.com
Pinnacle Food Group Limited Completes First Bench-Scale Fermentation of Recombinant Human Lactoferrin (rhLF) Using Methanol-Free Pichia Fermentation
rhLF expression from the Company's first-generation yeast strain confirmed in a 5-liter bench-scale fermenter; milestone supports further strain optimization and scale-up evaluation VANCOUVER, BC AND…
1 month ago reuters.com
PF Holdings launches tender offer for Italy's Pininfarina shares
Italian design group Pininfarina said on Wednesday that PF Holdings, a Dutch special purpose entity owned by India's Tech Mahindra and Mahindra & Mahindra , has launched a voluntary tender offer…
2 months ago gurufocus.com
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livest
Elanco's CLiK⢠Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds
12 months ago defenseworld.net
Reviewing Pinnacle Food Group (NASDAQ:PFAI) and Mission Produce (NASDAQ:AVO)
Pinnacle Food Group (NASDAQ: PFAI - Get Free Report) and Mission Produce (NASDAQ: AVO - Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will…
1 year ago defenseworld.net
Head to Head Survey: Pinnacle Food Group (NASDAQ:PFAI) and Corteva (NYSE:CTVA)
Pinnacle Food Group (NASDAQ: PFAI - Get Free Report) and Corteva (NYSE: CTVA - Get Free Report) are both consumer staples companies, but which is the superior investment? We will compare the two…
1 year ago businesswire.com
MedLumics® Announces the Publication of FIM Results for the AblaView® (PF) Ablation System in (AF) Patients, Including Clinical Safety and Our Ability to Predict Durable Lesions at 3 Months With 100% Specificity
MADRID--(BUSINESS WIRE)--“We would like to thank the investigation site team and particularly the investigators and proctors in this groundbreaking first-in human trial and for enabling the…
4 years ago gurufocus.com
Pharma Giants Go After $10 Billion Market With RSV Drugs
GlaxoSmithKline PLC ( GSK , Financial), Pfizer Inc. ( PFE , Financial) and Johnson & Johnson ( JNJ , Financial) should all know about mid-year if the shots they're developing for a common and…
-
8 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For August 3, 2018
Benzinga's Top Upgrades, Downgrades For August 3, 2018